ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy

Link
https://www.globenewswire.com/news-release/2026/04/20/3277007/0/en/ALK-announce…
Created date
Nasdaq ID
3277007
Last updated: 2026.04.20

Medical Science Liaison

EasyCruit ID
3619439
Department ID
119195
Location
Kraków, Poland
Vacancy URL
https://alkabello.easycruit.com/vacancy/3619439/119195
Expire Date
Last updated: 2026.04.17

Account Manager

EasyCruit ID
3619193
Department ID
109009
Location
Louvain-La-Neuve, Belgium
Vacancy URL
https://alkabello.easycruit.com/vacancy/3619193/109009
Expire Date
Last updated: 2026.04.22

Medical Science Liaison

EasyCruit ID
3619013
Department ID
109011
Location
Wallonia, Belgium
Vacancy URL
https://alkabello.easycruit.com/vacancy/3619013/109011
Expire Date
Last updated: 2026.04.17

Account Manager

EasyCruit ID
3618821
Department ID
109541
Location
Almere, Netherlands
Vacancy URL
https://alkabello.easycruit.com/vacancy/3618821/109541
Expire Date
Last updated: 2026.04.16

neffy® approved as the first needle-free anaphylaxis treatment of adults and children in Canada

Link
https://www.globenewswire.com/news-release/2026/04/15/3274254/0/en/neffy-approv…
Created date
Nasdaq ID
3274254
Last updated: 2026.04.15

QA Release Specialist / Delegated QP

EasyCruit ID
3617337
Department ID
109023
Location
Madrid, Spain
Vacancy URL
https://alkabello.easycruit.com/vacancy/3617337/109023
Expire Date
Last updated: 2026.04.14

Nine-month interim report (Q3) 2025 (unaudited)

Link
https://www.globenewswire.com/news-release/2025/11/12/3186544/0/en/Nine-month-i…
Created date
Nasdaq ID
3186544
Last updated: 2026.04.09

ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America

Link
https://www.globenewswire.com/news-release/2025/12/01/3197134/0/en/ALK-appoints…
Created date
Nasdaq ID
3197134
Last updated: 2026.04.09

Major shareholder announcement

Link
https://www.globenewswire.com/news-release/2025/12/19/3208755/0/en/Major-shareh…
Created date
Nasdaq ID
3208755
Last updated: 2026.04.09
Subscribe to